Nexalin Technology NXL
NASDAQ NXL
$0.33 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026)

Nexalin Technology (NXL) posted quarterly Accumulated Expenses of $640265.0 for Q1 2026, up 62.78% year-over-year from $393342.0 in Q1 2025, and little changed quarter-over-quarter from $642754.0 in Q4 2025.

Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026) Analysis & Trends

Nexalin Technology's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $640265.0 for Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 62.78% year-over-year to $640265.0; the TTM figure through Mar 2026 stood at $640265.0 (up 62.78% YoY), while the FY2025 annual figure was $642754.0, up 64.49% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $640265.0, roughly flat from $642754.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $642754.0 in Q4 2025, with the low at $124966.0 in Q2 2024.
  • The 5-year median for Accumulated Expenses is $393342.0 (2025), against an average of $425497.2.
  • The sharpest annual moves came in 2024 and 2025: Accumulated Expenses plunged 79.3% in 2024, then soared 188.08% in 2025.
  • Nexalin Technology's Accumulated Expenses stood at $539822.0 in 2022, then tumbled by 51.6% to $261284.0 in 2023, then soared by 49.55% to $390745.0 in 2024, then soared by 64.49% to $642754.0 in 2025, then fell by 0.39% to $640265.0 in 2026.
  • Business Quant data shows NXL's Accumulated Expenses at $640265.0 in Q1 2026, $642754.0 in Q4 2025, and $290031.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Nexalin Technology 7.04 Mn 6.03 Mn 8,897.00

Historic Data

Download Data
DateValue
Jun 30, 2026 858,504.00
Mar 31, 2026 640,265.00
Dec 31, 2025 642,754.00
Sep 30, 2025 290,031.00
Jun 30, 2025 360,004.00
Mar 31, 2025 393,342.00
Dec 31, 2024 390,745.00
Sep 30, 2024 132,847.00
Jun 30, 2024 124,966.00
Mar 31, 2024 355,713.00
Dec 31, 2023 261,284.00
Sep 30, 2023 606,891.00
Jun 30, 2023 603,633.00
Mar 31, 2023 597,660.00
Dec 31, 2022 539,822.00
Sep 30, 2022 442,501.00
Dec 31, 2021 611,795.00